Tu1756 PRECISION DOSING TEST IN OPTIMIZING INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY

Bincy Abraham; Ayesha Fatima; Robert Battat; Kristin Carroll; Esther A. Torres; Shervin Rabizadeh; David Ziring; Judith Gohndrone; Donald Lum; Ronen Arai; Tauseef Ali; Mark Allen; Adria A. Condino; Dan Joseph Stein; Akash Pandey; Terrence A. Barrett; Timothy E. Ritter; Harry Bray; Stephen B. Hanauer; Thierry Dervieux; Jean‐Frédéric Colombel

doi:10.1016/s0016-5085(23)03571-0

Related publications

Article2024

Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY

Stephen B. Hanauer, Esther A. Torres, Arun Swaminath, Thomas C. M. Lee, Shervin Rabizadeh, Morgan Check, Terrence A. Barrett, Casey Chapman, Ronen Arai, Jana G. Hashash, Madalina Butnariu, Thomas Meister, Jami Kinnucan, Eugene F. Yen, Dan Joseph Stein, Preetika Sinh, David Ziring, Rimma Sharposhnikov, Taha Qazi, Andrés Yarur, Patricia Aragon Han, Bincy Abraham

Article2025

The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program

Stephen B. Hanauer, Esther A. Torres, Patricia Aragon-Han, J. Casey Chapman, Arun Swaminath, Ronen Arai, Madalina Butnariu, Thomas C. Lee, Shervin Rabizadeh, Morgan Check, Terrence A. Barrett, Jana G. Hashash, Thomas Meister, Eugene F. Yen, Jami Kinnucan, Dan Joseph Stein, David Ziring, Rimma Shaposhnikov, Preetika Sinh, Taha Qazi, Andrés Yarur, Farah Monzur,

Article2021

Su445 SERUM INFLIXIMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH ACTIVE PERIPHERAL ARTHRALGIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Shaina Sekhri, Bharat Rao, Akanksha Mohananey, Poonam Beniwal‐Patel, Dan Joseph Stein, Andrés Yarur

Article2021

Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease

Shaina Sekhri, Bharat Rao, Akanksha Mohananey, Poonam Beniwal‐Patel, Alexandra Bruss, Dan Joseph Stein, Andrés Yarur

Article2009

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease†

Dan Joseph Stein, Ashwin N. Ananthakrishnan, Mazen Issa, John B. Williams, Dawn B. Beaulieu, Yelena Zadvornova, Anita Ward, Kathryn Johnson, Josh F. Knox, Sue Skaros, David G. Binion